The FFRangio System combines artificial intelligence and advanced computational science to obtain physiologic information from routine angiograms to better inform treatment decisions. Now, interventional cardiologists in the cath lab can quickly get more insight with less hassle.
As a leader in digital health innovations, CathWorks is dedicated to partnering with physicians to improve the health of patients by transforming how cardiovascular disease is diagnosed and treated.
CathWorks is backed by a strong group of investing partners.
Our partnership with Medtronic underscores their commitment to investing in innovative technologies that support physicians and patients from diagnosis to treatment and CathWorks’ FFRangio® System’s potential to disrupt traditional FFR and revolutionize the management of coronary artery disease.
